# Prognostic and Predictive Impact of Circulating Tumor DNA in Gastric Cancer Treatment

> **NCT02674373** · — · UNKNOWN · sponsor: **Association des Gastroentérologues Oncologues** · enrollment: 200 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02674373
- **Lead sponsor:** Association des Gastroentérologues Oncologues
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-09
- **Primary completion:** 2017-09
- **Final completion:** 2019-09
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2016-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02674373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02674373, "Prognostic and Predictive Impact of Circulating Tumor DNA in Gastric Cancer Treatment". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02674373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*